Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0692
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction ; day:4 ; month:7 ; year:2022 ; pages:1-12
Clinical research in cardiology ; (4.7.2022), 1-12
- Creator
-
Straw, Sam
Cole, Charlotte A.
McGinlay, Melanie
Drozd, Michael
Slater, Thomas A.
Lowry, Judith E.
Paton, Maria F.
Levelt, Eylem
Cubbon, Richard M.
Kearney, Mark T.
Witte, Klaus K.
Gierula, John
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-022-02053-8
- URN
-
urn:nbn:de:101:1-2022082318451788951484
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Straw, Sam
- Cole, Charlotte A.
- McGinlay, Melanie
- Drozd, Michael
- Slater, Thomas A.
- Lowry, Judith E.
- Paton, Maria F.
- Levelt, Eylem
- Cubbon, Richard M.
- Kearney, Mark T.
- Witte, Klaus K.
- Gierula, John
- SpringerLink (Online service)
Other Objects (12)
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction
Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction
Right ventricular ejection fraction
The Increasing Complexity of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction and Challenges for Real-world Implementation
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction
Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction
Right ventricular ejection fraction
The Increasing Complexity of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction and Challenges for Real-world Implementation
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study
Real-world comparative effectiveness of ARNI versus ACEi/ARB in HF with reduced or mildly reduced ejection fraction
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
Prognostic impact of prior LVEF in patients with heart failure with mildly reduced ejection fraction
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction
Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
Characteristics associated with ventricular tachyarrhythmias and their prognostic impact in heart failure with mildly reduced ejection fraction
Right ventricular ejection fraction
The Increasing Complexity of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction and Challenges for Real-world Implementation
Predictors of mortality in heart failure patients with reduced or mildly reduced Ejection Fraction: The CASABLANCA HF Study